Vorinostat Plus Hydroxychloroquine Versus Regorafenib in Colorectal Cancer

ABSTRACT: This will be a randomized phase II clinical trial of patients with histologic documentation of metastatic colorectal cancer, who have received local and currently approved standard therapies, excluding RGF.

DISEASE(S): Colorectal Cancer,Colorectal Neoplasms

PROVIDER: 2180232 | ecrin-mdr-crc |

REPOSITORIES: ECRIN MDR